Expanding the universe of druggable targets with AI-powered protein design

Mission

Our mission is to generate new therapeutic opportunities by advancing AI and experimental technologies for drug design

Interested in working with us?

Careers

Team

Our founders developed the first protein language models in George Church's Lab and founded the company to combine generative models with massively multiplex experiments to design protein based therapies for applications where traditionally discovery has shown limited success.

We're a small, technical, fully in-person team motivated to advance drug design through the development of new AI and experimental technologies. We're a mix of machine learning and wet-lab scientists, and value science and engineering above all else.

Surge Biswas

Co-founder & CEO

Frances Anastassacos

Co-founder & President

Allison Sheen

Adithya Paramasivam

Bridget Li

Connor Blankenship

Sunita Subramanian

Srihari Ganesh

Alex Blanco

Mark Desimone

Katie Warfel

Varun Tekur

Arlinda Rezhdo

Tony Wu

Devashish Prasad

Latest News

Backed by